Player is loading...

Embed

Embed code

Transcriptions

Note: this content has been automatically generated.
00:00:00
i remember correctly you had only
00:00:02
twenty-six percent of patients which
00:00:04
were using only or taking all your
00:00:07
methodology see that in substance and
00:00:10
effect of the other substance or the
00:00:12
pair the moms who had higher doses had
00:00:15
also more risk to have other trucks or
00:00:18
it's okay my answer in French it can
00:00:21
answer in front on that pressure the
00:00:24
love
00:00:25
let's not have a defined by should call
00:00:27
essentially zero to 60 so just go ahead
00:00:29
dude starts getting is it you do tois
00:00:32
get the like okay in a lamb you cannot
00:00:35
be a little girl doesn't depress
00:00:38
available within my power she the LSU
00:00:41
see scooters program was your fiancée
00:00:48
do we know that man but not so good for
00:00:50
something so i'll make them good thank
00:00:57
you very much for your presentation and
00:00:59
you may be convened on the effect size
00:01:01
of the association between such as
00:01:06
treatment duration and long-term
00:01:09
outcomes effect size the FX strong
00:01:12
association i don't know presented a few
00:01:17
are aware that this one is going to
00:01:20
believe the color
00:01:21
what is it away right
00:01:25
I don't mean to girlfriend and I'm not
00:01:28
ritual known that be enough
00:01:37
question in french i will ask the
00:01:43
English is the cutoff of 60 milligrams a
00:01:46
day between high dolls and low-dose
00:01:48
instead something is to choose your
00:01:50
literature
00:01:51
yeah but in other studies we found that
00:01:54
they use this kind of so that's why we
00:01:56
use a seven communities could be your
00:01:59
last question
00:02:00
thank you for that nice presentation i
00:02:02
have a question related to what was
00:02:04
discussed before
00:02:06
do you have any biological materials
00:02:09
such as meconium where you can quantify
00:02:11
that alcohol consumption because that's
00:02:13
the major confounder for cognitive
00:02:16
outcome
00:02:17
now we didn't and also the low levels of
00:02:19
cognitive performance
00:02:21
did you have a control group now we
00:02:23
didn't know there's a lot of studies
00:02:26
show that when you compare to similar
00:02:29
socioeconomic status control group the
00:02:32
different or the effects actually that
00:02:35
they didn't hear we didn't have to thank
00:02:37
you thank you thank you very much so we
00:02:41
were close the session

Share this talk: 


Conference program

Welcome Words
M. Roth-Kleiner, R. Arlettaz Mieth
10 Jan. 2017 · 9:33 a.m.
526 views
Short Reports Introduction
E. Giannoni, T. Karen, Resp. Lausanne, Zürich
10 Jan. 2017 · 9:38 a.m.
Association of Axonal Injury and Preeclampsia
Katrina Evers, Neonatology UKBB
10 Jan. 2017 · 9:39 a.m.
182 views
Q&A - Association of Axonal Injury and Preeclampsia
Katrina Evers, Neonatology UKBB
10 Jan. 2017 · 9:44 a.m.
102 views
Retinopathy of Prematurity
Roland Gerull, Bern
10 Jan. 2017 · 9:47 a.m.
154 views
Q&A - Retinopathy of Prematurity
Roland Gerull, Bern
10 Jan. 2017 · 9:54 a.m.
Parechovirus Infection: A Rare Cause of Neonatal Encephalitis (in French)
Dr Truant AS, Cheffe de clinique, Néonatologie, CHUV, Lausanne
10 Jan. 2017 · 9:59 a.m.
350 views
Q&A - Parechovirus Infection: A Rare Cause of Neonatal Encephalitis
Dr Truant AS, Cheffe de clinique, Néonatologie, CHUV, Lausanne
10 Jan. 2017 · 10:04 a.m.
234 views
112 views
Genetic Susceptibility to Neonatal Group B Streptococcal Disease
Alessandro Borghesi, Fellay lab, EPFL
10 Jan. 2017 · 10:17 a.m.
131 views
Q&A - Genetic Susceptibility to Neonatal Group B Streptococcal Disease
Alessandro Borghesi, Fellay lab, EPFL
10 Jan. 2017 · 10:25 a.m.
Psychomotor Development in Children Prenatally Exposed to Methadone
G. Grand-Guillaume-Perrenoud, Pediatrics, Children's University Hospital Geneva
10 Jan. 2017 · 10:27 a.m.
Q&A - Psychomotor Development in Children Prenatally Exposed to Methadone
G. Grand-Guillaume-Perrenoud, Pediatrics, Children's University Hospital Geneva
10 Jan. 2017 · 10:34 a.m.
Introduction to Christoph Berger's Presentation
C. Kind, R. Gerull, Resp. St.Gallen, Bern
10 Jan. 2017 · 10:37 a.m.
Vertical Infections: An Update
Christoph Berger, Zürich
10 Jan. 2017 · 10:40 a.m.
253 views
Q&A - Vertical Infections: An Update
Christoph Berger, Zürich
10 Jan. 2017 · 11:15 a.m.
Introduction to Eric Giannoni's Presentation
R. Pfister, S. Kämpfen, Resp. Geneva, Basel
10 Jan. 2017 · 11:44 a.m.
Sepsis, Antibiotics and Resistances: Where Are We?
Christoph Bührer, Berlin
10 Jan. 2017 · 2:21 p.m.
145 views
Use and Abuse of Antibiotics in Neonatology
Martin Stocker, Lucerne
10 Jan. 2017 · 2:50 p.m.
291 views
Panel Discussion : Controversies on Use of Antibiotics in Neonatology
Martin Stocker, Christoph Berger, Eric Giannoni, Christoph Bührer
10 Jan. 2017 · 3:10 p.m.
105 views
Introduction to Christoph Bührer's Presentation
Romaine Arlettaz Mieth , Neonatologist, Zürich, President of the Organizing Committee
10 Jan. 2017 · 3:47 p.m.
Evidence-Based Haemodynamic Management in Neonatal Sepsis
Christoph Bührer, Berlin
10 Jan. 2017 · 3:48 p.m.
416 views
Q&A - Evidence-Based Haemodynamic Management in Neonatal Sepsis
Christoph Bührer, Berlin
10 Jan. 2017 · 4:16 p.m.
SwissNeoDose Project
Marc Pfister, Ped Pharmacology, UKBB
10 Jan. 2017 · 4:20 p.m.
112 views
Awards (Case of the Year; Milupa; Best Poster Case Report; Best Oral Short Presentation) & Closing Comments
Matthias Roth-Kleiner, CHUV, President of the SSN
10 Jan. 2017 · 4:30 p.m.